Trial no.:
|
PACTR201901866476410 |
Date of Approval:
|
30/01/2019 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Evaluation of The Regenerative Potential of a Novel Treated Dentin Matrix Hydrogel and Bioactive Dentin Substitute in Direct Pulp Capping
|
Official scientific title |
Clinical And Histological Evaluation of The Regenerative Potential of a Novel Treated Dentin Matrix Hydrogel and Bioactive Dentin Substitute in Direct Pulp Capping (A Randomized Controlled Trial)
|
Brief summary describing the background
and objectives of the trial
|
Biodentine is a new bioactive calcium silicate-based cement known as “bioactive dentin substitute” with dentin-like mechanical properties. MTA has been investigated in various human and animal experimental models. On the other hand, studies comparing MTA with Biodentine in terms of vital pulp treatment behavior are rather limited. Regenerating dentin and preserving pulp vitality are the two key targets for the treatment of dental pulp exposure. In view of the increasing demand for maintaining dentin-pulp complex vitality, there has been increasing interest in investigating new methods for tissue replacement.
Treated dentin matrix (TDM) has recently been shown to be a suitable scaffold for human dentin regeneration because of its high bioinductive properties. However, the TDM has less physical stability and sealing ability as a pulp capping material. Therefore, TDM will be further fabricated into TDM hydrogel as an injectable scaffold. A novel TDM hydrogel is composed of TDM powder and sodium alginate as an anionic natural polymer typically extracted from brown seaweeds. The aim of the present study is to assess the clinical and radiographic success of the direct pulp capping procedure done in traumatically exposed permanent posterior teeth using Treated dentin matrix hydrogel (TDMH), Biodentine and Mineral trioxide aggregate (MTA), and to study histologically the pulpal response to these pulp capping materials in sound premolars scheduled to be extracted for orthodontic reasons.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Oral Health |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Devices |
Anticipated trial start date |
15/02/2019 |
Actual trial start date |
15/02/2019 |
Anticipated date of last follow up |
15/08/2010 |
Actual Last follow-up date |
15/08/2020 |
Anticipated target sample size (number of participants) |
45 |
Actual target sample size (number of participants) |
45 |
Recruitment status |
Not yet recruiting |
Publication URL |
|
|